Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-20 Sale | 2023-09-21 5:06 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 742 | $1.245 | $924 | 68,318 (Direct) | View |
| 2023-08-18 Sale | 2023-08-21 4:32 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 243 | $1.414 | $344 | 69,060 (Direct) | View |
| 2023-07-19 Sale | 2023-07-20 4:38 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 106 | $1.585 | $168 | 69,303 (Direct) | View |
| 2023-06-21 Sale | 2023-06-22 4:45 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 603 | $1.483 | $894 | 69,409 (Direct) | View |
| 2023-05-17 Sale | 2023-05-18 4:07 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 219 | $1.624 | $356 | 70,012 (Direct) | View |
| 2023-05-10 Purchase | 2023-05-11 4:11 pm | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 31,500 | $1.5502 | $48,831 | 36,500 (Direct) | View |
| 2023-05-10 Purchase | 2023-05-11 4:10 pm | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 8,111 | $1.495 | $12,126 | 8,111 (Direct) | View |
| 2023-05-09 Purchase | 2023-05-10 4:12 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 20,000 | $1.2596 | $25,192 | 312,816 (Direct) | View |
| 2023-04-19 Sale | 2023-04-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 115 | $1.278 | $147 | 70,231 (Direct) | View |
| 2023-04-19 Sale | 2023-04-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,290 | $1.272 | $1,641 | 83,663 (Direct) | View |
| 2023-04-19 Sale | 2023-04-20 4:11 pm | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 938 | $1.271 | $1,192 | 127,064 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:19 pm | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 3,808 | $1.7819 | $6,785 | 128,002 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 6,999 | $1.783 | $12,479 | 292,816 (Direct) | View |
| 2023-03-17 Sale | 2023-03-20 4:16 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 526 | $1.7823 | $937 | 70,346 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:22 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 5,090 | $5.055 | $25,730 | 48,572 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:21 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 5,441 | $5.056 | $27,510 | 194,815 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 4:20 pm | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 3,884 | $5.065 | $19,672 | 103,060 (Direct) | View |
| 2023-01-18 Sale | 2023-01-19 4:58 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,347 | $6.996 | $44,404 | 64,453 (Direct) | View |
| 2023-01-18 Sale | 2023-01-19 4:58 pm | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 1,191 | $6.985 | $8,319 | 106,944 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:35 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 250,000 | $0 | 318,318 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:34 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 350,000 | $0 | 477,064 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:33 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 250,000 | $0 | 333,663 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:32 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 370,000 | $0 | 443,936 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:30 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 1,096,000 | $0 | 1,408,816 (Direct) | View |
| 2023-08-08 Option Award | 2023-08-09 4:30 pm | N/A 2033-08-08 | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 89,300 | $1.62 | 89,300 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 26,150 | $0 | 51,404 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director | 26,150 | $0 | 54,566 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:08 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 26,150 | $0 | 26,150 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:08 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 26,150 | $0 | 62,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director | 26,150 | $0 | 57,918 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 26,150 | $0 | 49,599 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:06 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 26,150 | $0 | 34,261 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:05 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director | 26,150 | $0 | 49,599 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:23 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 107,400 | $0 | 171,853 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:22 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 116,800 | $0 | 165,372 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:21 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 550,000 | $0 | 744,815 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:21 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 48,200 | $0 | 112,936 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:20 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer | 151,250 | $0 | 254,310 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-12 4:07 pm | N/A 2032-12-09 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 110,000 | $0 | 129,771 (Direct) | View |
Ownership | 2022-11-16 4:11 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 0 | $0 | 19,771 (Direct) | View |